EQ
EQ
NASDAQ · Biotechnology

Equillium Inc

$1.68
+0.01 (+0.60%)
As of Sep 28, 10:23 PM ET ·
Analyst Consensus
Strong Buy
18
Analysts
High
Coverage
Buy 17 94%
Hold 1 6%
Sell 0 0%
Price Target
Analyst Price Target +1,504.8% upside
Low Target $18.17
Average Target $26.96
High Target $35.46
Current Price $1.68
Current
$1.68
Target
$26.96
$18.17 $26.96 avg $35.46
Scenario Analysis
Bear Case
$18.17
981.5%
Low target
Base Case
$26.96
+1,504.8%
Avg target
Bull Case
$35.46
+2,010.7%
High target
Risk/Reward
2.0x
Favorable
Price in Context
52-Week High
$3.54
-52.5% from high
52-Week Low
$0.76
+121.1% from low
Target vs 52W High
$26.96
+661.6% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -3.3%
AMGN
Amgen Inc
Hold 43 47% $190.87 -54.4%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +138.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -16.9%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -89.8%
MRNA
Moderna Inc
Hold 30 37% $149.45 -24.2%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -65.3%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -43.4%